BIOASTER, partner with the European Project TRANSVAC2 coordinated by the European Vaccine Initiative (EVI)

The European Commission announces the start of the TRANSVAC2 project, coordinated by the European Vaccines Initiative (EVI) in the context of the Horizon 2020 Program.
This project will offer services the scientific community to support innovation in the field of vaccines through a network of 26 European partners, including BIOASTER.

More information: Press release European Vaccine Initiative.